Structure-activity relationships of anthraquinones in the decrease of intestinal motility

Journal of Pharmacy and Pharmacology

Volumn 52, Issue 7, 2000, Pages 839-841

  Kuo, Daih Huang ^a   Kuo, Sheng Chu ^b   Cheng, Juei Tang ^c  

^a TAJEN INSTITUTE OF TECHNOLOGY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALDEHYDE; ANTHRAQUINONE; ANTHRAQUINONE DERIVATIVE; CARBOXYLIC ACID; EMODIN; HYDROXYL GROUP; METHYL GROUP;

ANIMAL TISSUE; ARTICLE; DRUG ANTAGONISM; DRUG INHIBITION; DRUG STRUCTURE; ESTERIFICATION; IN VITRO STUDY; INTESTINE MOTILITY; MALE; NONHUMAN; RABBIT; STRUCTURE ACTIVITY RELATION;

EID: 0033941586     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357001774516     Document Type: Article

References (14)

1. Bonnycastle, D. D. (1965) Cathartics and laxatives. In: Di Palma, J. R. (ed.) Drill's Pharmacology in Medicine. 3rd edn, McGraw-Hill Press, New York, pp 747-759
2. Cohen, S. D., Mijovic, M. V., Newman, G. A. (1968) Photochemical formation of an anthracene from 4,4′-diethoxycarbonylstibene. Chem. Commun. 12: 722-723
3. de Wite, P., Lemli, L. (1990) The metabolism of anthranoid laxatives. Hepatogastro-enterology. 37: 601-605
4. Gaginella, T. S., Base, P. (1978) Laxatives: an update on mechanism of action. Life Sci. 23: 1001-1009
5. Hogue, V. W. (1996) Diarrhea and constipation. In: Herfindal, E. T., Gourley, D. R., Hard, L. L. (eds) Clinical Pharmacy and Therapeutics. 6th edn, Williams & Wilkins Press, Baltimore, pp 517-531
6. Hung, H. C., Chu, S. H., Chao Lee, P. D. (1991) Vasorelaxants from Chinese Herbs, emodin and scoparone, possess immunosuppressive properties. Eur. J. Pharmacol. 198: 211-213
7. Jacob, W. (1921) 2-Anthraquinone-aldehyde and some of its derivatives. Helvetica Chim. Acta 4: 782-788
8. Jin, Z. H., Ma, D. L., Lin, X. Z. (1994) Study on effect of emodin on the isolated intestinal smooth muscle of guinea pigs. (Chinese ed.) Chung-Kuo Chung Hsi i Chieh Ho Tsa Chih. 14: 429-431
9. John, H., Arthur G. P. (1923) Reduction of the hydroxyanthraquinones. Part II. J. Chem. Soc. (London) 123: 2029-2037
10. Kuo, D. H., Cheng, J. T., Tu, Y. S., Kuo, S. C. (1996) Synthesis of anthraquinone-2-carboxylic acid derivatives as inhibitors of small intestine motility. Chinese Pharm. J. 48: 313-320
11. Morgan, G. T., Coulson, E. (1929) A. Synthesis of anthracene homologs. I. 2, 6- and 2, 7-dimethylanthraquinones. J. Chem. Soc. P2: 2203-2214
12. Moshchinskaya, N. K., Kutsygina, V. V., Kovalevskaya, L. I., Korenyako, V. A., Shapovalova, V. T. (1980) Use of dimethylanthracenes for preparing anthraquinone 2,6 and 2,7-dicarboxylic acids by liquid-phase oxidation. Ukr. Khim. Zh. (Russ.) 46: 77-80
13. Riecken, E. O., Zeitz, M., Emde, C., Hopert, R., Witzel, L., Hintze, R., Marsch-Ziegler, U., Vester, J. C. (1990) The effect of an anthraquinone laxative on colonic nerve tissue: a controlled trial in constipated women. Z. fur Gastroenterol. 28: 660-664
14. Wang, H. H. (1993) Antitrichomonal action of emodin in mice. J. Ethnopharmacol. 40: 111-116